DACH1通过激活NRF2信号来减轻慢性阻塞性肺病中的呼吸道炎症
Qian Huang1, Yiya Gu1, Jixing Wu1
1Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; and.
概括
减少大犬同类素1 (DACH1) 表达会恶化慢性阻塞性肺病 (COPD) 的呼吸道炎症. 恢复DACH1通过激活NRF2信号来保护免受香烟烟雾引起的肺损伤.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 炎症研究 炎症研究
背景情况:
- 慢性阻塞性肺病 (COPD) 是呼吸系统疾病的主要原因,通常与香烟烟雾 (CS) 相关.
- 在COPD病变发生过程中,大犬同源1 (DACH1) 的作用尚不清楚.
- 在COPD患者中,DACH1的表达减少.
研究的目的:
- 研究DACH1在COPD中的作用.
- 阐明DACH1在CS引起的气道炎症中的潜在机制.
- 探索DACH1作为COPD的潜在治疗点.
主要方法:
- 测量了COPD患者和对照患者的肺组织中的DACH1表达.
- 使用了特定于气道表皮的DACH1-knockdown和DACH1-过度表达的小鼠模型,暴露于CS.
- 在体外用CS提取物刺激的人类支气管上皮细胞中研究了DACH1的机制.
- 评估了DACH1和NRF2信号通路之间的相互作用.
主要成果:
- 与非吸烟者和没有COPD的吸烟者相比,COPD患者的DACH1表达显著降低,特别是在呼吸道上皮质中.
- 在小鼠中,DACH1倒置加剧了CS诱导的气道炎症和肺功能下降.
- DACH1过度表达给予了对CS诱导的气道炎症和肺功能障碍的保护.
- 在暴露于CS提取物的人类支气管上皮细胞中,DACH1调节IL-6和IL-8分泌.
- DACH1直接与NRF2 (核因子红色素2相关因子2) 的促进体结合,激活其信号通路以减少炎症.
结论:
- 减少DACH1的表达是COPD的一个关键特征,有助于呼吸道炎症.
- DACH1通过激活NRF2通路,对CS诱导的肺损伤产生保护作用.
- 针对DACH1的治疗策略可能为COPD治疗提供一种新的方法.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:26COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20COPD: Pathogenesis and Clinical Features
267
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
267
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
01:17Drugs Used in Lower Respiratory Disorders: Overview
428
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
428